Abbott receives CE Mark approval for Alinity h-series haematology system

Abbott has announced that its new Alinity h-series integrated system for haematology testing has received European CE Mark approval.

The new device integrates the Alinity hq standalone haematology analyser with the capabilities of the Alinity hs slide maker and stainer module, providing a combined solution that is 20 percent faster per sq m than other currently available integrated haematology systems.

Offering a throughput of 133 complete blood counts per sq m, the system also delivers an enhanced workflow by reducing the amount of time required to move samples around the laboratory, as well as greater flexibility and reduced wait times.

Other key features include an intuitive user experience, with iconography, colour-coding and reporting features shared with other Alinity platforms, plus a common method for sample loading and reagent management.

Brian Blaser, executive vice-president for diagnostics products at Abbott, said: "With built-in simplicity designed specifically for haematology testing, the Alinity h-series is smaller, faster, and more automated than current systems."

With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.